Clinical application of nebulized opioids for treatment of dyspnoea in patients with malignant disease
- 1 May 1994
- journal article
- case report
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 2 (3) , 184-187
- https://doi.org/10.1007/bf00417478
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Case studies outlining use of nebulized morphine for patients with end-stage chronic lung and cardiac diseaseJournal of Pain and Symptom Management, 1993
- Does pharmacological treatment affect the sensation of breathlessness in terminal cancer patients?Palliative Medicine, 1991
- Effects of morphine on the dyspnea of terminal cancer patientsJournal of Pain and Symptom Management, 1990
- Long-term management of respiratory symptoms in advanced cancerJournal of Pain and Symptom Management, 1990
- Dyspnoea in advanced cancer - a flow diagramPalliative Medicine, 1990
- Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease.Thorax, 1989
- OPIOID INHIBITION OF NEURALLY MEDIATED MUCUS SECRETION IN HUMAN BRONCHIThe Lancet, 1989
- Heroin inhalation and asthma.BMJ, 1988
- Dihydrocodeine for breathlessness in "pink puffers".BMJ, 1983
- Effects of Dihydrocodeine, Alcohol, and Caffeine on Breathlessness and Exercise Tolerance in Patients with Chronic Obstructive Lung Disease and Normal Blood GasesNew England Journal of Medicine, 1981